id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1978-N-2157-0006,FDA,FDA-1978-N-2157,Acknowledgement Letter FDA/DDM to The Proctor & Gamble Company,Other,Acknowledgement Letter/Receipt,1995-12-22T05:00:00Z,1995,12,,,2019-08-01T18:37:54Z,,0,0,09000064805a6715
FDA-1978-N-2157-0004,FDA,FDA-1978-N-2157,"Acknowledgement Letter FDA/DDM to Huls America, Inc.",Other,Acknowledgement Letter/Receipt,1995-12-22T05:00:00Z,1995,12,,,2019-08-01T18:45:05Z,,0,0,09000064805a6713
FDA-1978-N-2157-0005,FDA,FDA-1978-N-2157,"Acknowledgment Letter from FDA/DDM to Smith & Nephew United Inc. re: Citizen Petition from Smith & Nephew United, Inc.",Other,Acknowledgement Letter/Receipt,1995-12-22T05:00:00Z,1995,12,,,2019-06-03T13:50:38Z,,0,0,09000064805a6714
FDA-1995-P-0044-0003,FDA,FDA-1995-P-0044,"FDA/DDM to Westwood Squibb Pharmaceuticals, Inc",Other,ACK-Acknowledgement Letter,1995-11-27T05:00:00Z,1995,11,,,2008-05-16T23:07:30Z,,0,0,090000648056143f
FDA-1978-N-0018-0144,FDA,FDA-1978-N-0018,"Letter from The Assembly State of New York, Albany to FDA",Other,Letter(s),1995-11-22T05:00:00Z,1995,11,,,2019-07-23T18:14:02Z,,0,0,090000648055a251
FDA-1995-P-0023-0001,FDA,FDA-1995-P-0023,HFA-305 to Columbia University of School of Public Health,Other,ACK-Acknowledgement Letter,1995-11-20T05:00:00Z,1995,11,,,2008-05-16T23:07:11Z,,0,0,0900006480559662
FDA-1995-P-0010-0001,FDA,FDA-1995-P-0010,Acknowledgement Letter to American Feed Industry Association and Animal Health Institute,Other,ACK-Acknowledgement Letter,1995-11-14T05:00:00Z,1995,11,,,2013-07-28T01:44:10Z,,0,0,090000648055842e
FDA-1978-N-0018-0143,FDA,FDA-1978-N-0018,"Memorandum of Meeting Between FDA and Givaudan-Roure Corporation et al August 11, 1995",Other,Memorandum,1995-11-01T05:00:00Z,1995,11,,,2019-07-23T16:14:40Z,,0,0,090000648055a248
FDA-1995-P-0042-0001,FDA,FDA-1995-P-0042,Acknowledgment Letter from FDA DMB to Competitive Enterprise Institute,Other,ACK-Acknowledgement Letter,1995-10-31T05:00:00Z,1995,10,,,2025-09-15T16:26:01Z,,0,0,090000648056126b
FDA-1982-P-0001-0011,FDA,FDA-1982-P-0001,FDA/Associate Commissioner for Regulatory Affairs,Other,PDN-Petition Denial,1995-10-27T04:00:00Z,1995,10,,,2008-05-30T22:53:10Z,,0,0,090000648050d497
FDA-1978-N-0018-0142,FDA,FDA-1978-N-0018,"Letter from FDA CDER to the Honorable Audrey I. Pheffer & Harvey Weisenberg, New York State Assembly",Other,Letter(s),1995-10-26T04:00:00Z,1995,10,,,2019-07-23T16:02:30Z,,0,0,090000648055a246
FDA-1995-P-0004-0001,FDA,FDA-1995-P-0004,Acknowledgement Letter from FDA DMB to Bock Pharmacal Co,Other,Acknowledgement Letter/Receipt,1995-10-12T04:00:00Z,1995,10,,,2024-06-06T01:00:29Z,,0,0,09000064805583cb
FDA-1980-N-0074-0032,FDA,FDA-1980-N-0074,"Letter from FDA HFD-811 to Cosmetic, Toiletry and Fragrance Association",Other,Letter(s),1995-10-04T04:00:00Z,1995,10,,,2022-04-21T20:23:50Z,,0,0,09000064805bb362
FDA-1995-S-0039-0001,FDA,FDA-1995-S-0039,Memorandum from FDA/CFSAN,Other,M-Memorandum,1995-09-27T04:00:00Z,1995,9,,,2016-09-30T14:17:47Z,,0,0,090000648055bacf
FDA-1991-P-0020-0001,FDA,FDA-1991-P-0020,Letter from FDA to Bass & Ullman on Behalf of National Association of Pharmaceutical Manufacturers,Other,Letter(s),1995-08-28T04:00:00Z,1995,8,,,2023-11-16T21:52:45Z,,0,0,09000064805284a2
FDA-1995-P-0006-0003,FDA,FDA-1995-P-0006,"Acknowledgment Letter from FDA DMB to Mikart, Inc.",Other,Acknowledgement Letter/Receipt,1995-08-21T04:00:00Z,1995,8,,,2025-09-19T00:46:55Z,,0,0,0900006480558400
FDA-1995-P-0006-0002,FDA,FDA-1995-P-0006,"Acknowledgment Letter from FDA DMB to Mikart, Inc.",Other,Acknowledgement Letter/Receipt,1995-08-21T04:00:00Z,1995,8,,,2025-09-19T00:46:31Z,,0,0,09000064805583ff
FDA-1995-P-0006-0004,FDA,FDA-1995-P-0006,"Acknowledgment Letter from FDA DMB to Mikart, Inc.",Other,Acknowledgement Letter/Receipt,1995-08-21T04:00:00Z,1995,8,,,2025-09-19T00:47:17Z,,0,0,0900006480558401
FDA-1995-P-0006-0001,FDA,FDA-1995-P-0006,"Acknowledgment Letter from FDA DMB to Mikart, Inc.",Other,Acknowledgement Letter/Receipt,1995-08-18T04:00:00Z,1995,8,,,2025-09-19T00:45:55Z,,0,0,09000064805583f5
FDA-1995-P-0002-0002,FDA,FDA-1995-P-0002,"HFA-305 to Kleinfeld, Kaplan & Becker",Other,ACK-Acknowledgement Letter,1995-08-11T04:00:00Z,1995,8,,,2008-05-16T23:06:15Z,,0,0,0900006480558353
FDA-1995-P-0360-0002,FDA,FDA-1995-P-0360,Acknowledgement Letter to Citizen Petition from Center for Science in the Public Interest,Other,Acknowledgement Letter/Receipt,1995-08-04T04:00:00Z,1995,8,2015-04-05T04:00:00Z,,2015-04-05T13:56:53Z,,0,0,0900006481a8be2c
FDA-1995-P-0360-0001,FDA,FDA-1995-P-0360,Citizen Petition from Center for Science in the Public Interest,Other,Citizen Petition,1995-08-04T04:00:00Z,1995,8,2015-04-05T04:00:00Z,,2015-04-05T13:57:11Z,,0,0,090000648059a009
FDA-1995-P-0016-0003,FDA,FDA-1995-P-0016,HFA-305,Other,ACK-Acknowledgement Letter,1995-07-28T04:00:00Z,1995,7,,,2008-05-16T23:06:36Z,,0,0,0900006480558657
FDA-1988-V-0025-0001,FDA,FDA-1988-V-0025,Approval for Variance from Laser Images Productions,Other,Approval for Variance (VRA),1995-07-20T04:00:00Z,1995,7,,,2023-12-01T16:06:11Z,,0,0,09000064804763b9
FDA-1995-P-0018-0002,FDA,FDA-1995-P-0018,"Acknowledgment Letter from FDA DMB to Mikart, Inc.",Other,Acknowledgement Letter/Receipt,1995-07-20T04:00:00Z,1995,7,,,2025-07-07T17:49:13Z,,0,0,09000064805592aa
FDA-1995-P-0018-0001,FDA,FDA-1995-P-0018,"Acknowledgment Letter from FDA DMB to Mikart, Inc.",Other,Acknowledgement Letter/Receipt,1995-07-20T04:00:00Z,1995,7,,,2025-10-11T08:00:48Z,,0,0,0900006480559274
FDA-1978-N-0018-0141,FDA,FDA-1978-N-0018,Letter from FDA CDER to Paul Pierce,Other,Letter(s),1995-07-13T04:00:00Z,1995,7,,,2019-07-31T14:03:30Z,,0,0,090000648055a240
FDA-1995-P-0017-0001,FDA,FDA-1995-P-0017,HFS-150 to The Quaker Oats Company,Other,ACK-Acknowledgement Letter,1995-07-06T04:00:00Z,1995,7,,,2008-05-16T23:06:49Z,,0,0,0900006480558802
FDA-1995-P-0041-0001,FDA,FDA-1995-P-0041,"Acknowledgment Letter from FDA DDM to Compressed Gas Association, Inc.",Other,Acknowledgement Letter/Receipt,1995-06-26T04:00:00Z,1995,6,,,2017-02-14T15:24:15Z,,0,0,09000064805611af
FDA-1995-P-0051-0004,FDA,FDA-1995-P-0051,Acknowledgment Letter from FDA DMB to Public Citzen Health Research Group,Other,Acknowledgement Letter/Receipt,1995-06-16T04:00:00Z,1995,6,,,2025-09-15T21:41:17Z,,0,0,0900006480561e5c
FDA-2020-D-2006-0001,FDA,FDA-2020-D-2006,"Guidance for Industry: Letter to Manufacturers, Importers, and Distributors of Imported Candy and Candy Wrappers",Other,Guidance,1995-06-13T04:00:00Z,1995,6,2020-09-23T04:00:00Z,,2024-11-06T23:39:05Z,,1,0,09000064848746a5
FDA-1995-P-0058-0001,FDA,FDA-1995-P-0058,"Acknowledgment Letter from FDA DMB to Lerch, McDaniel & Kauo, PLC",Other,Acknowledgement Letter/Receipt,1995-06-06T04:00:00Z,1995,6,,,2025-09-09T09:00:16Z,,0,0,090000648056c3d3
FDA-1995-P-0015-0001,FDA,FDA-1995-P-0015,"Acknowledgement Letter from FDA HFA-305 to Akin, Grump, Strauss, Hauer & Feld, L.L.P",Other,Acknowledgement Letter/Receipt,1995-05-30T04:00:00Z,1995,5,,,2022-08-17T18:52:38Z,,0,0,0900006480558564
FDA-1978-N-0018-0140,FDA,FDA-1978-N-0018,"Memorandum of Telephone Conversation Between Dr. Weinstock, Brown University & Jeanne Rippere, FDA April 18, 1995",Other,Memorandum,1995-05-11T04:00:00Z,1995,5,,,2019-07-31T14:07:58Z,,0,0,090000648055a230
FDA-1978-N-0018-0139,FDA,FDA-1978-N-0018,"Memorandum of Telephone Conversation Between Dr. J. Ferguson, Boots Contract Manufacturing  & Jeanne Rippere, FDA May 1, 1995",Other,Memorandum,1995-05-11T04:00:00Z,1995,5,,,2019-07-23T13:31:51Z,,0,0,090000648055a22d
FDA-1994-P-0013-0002,FDA,FDA-1994-P-0013,Letter from FDA CFSAN to Minnesota Cultivated Wild Rice Council- Envelope,Other,Letter(s),1995-04-24T04:00:00Z,1995,4,,,2024-06-27T03:31:05Z,,0,0,09000064804fc7db
FDA-1995-P-0043-0001,FDA,FDA-1995-P-0043,"Acknowledgement Letter to Sonnenreich, Roccograndi & Woo",Other,Acknowledgement Letter/Receipt,1995-04-24T04:00:00Z,1995,4,,,2012-09-20T17:09:08Z,,0,0,090000648056133f
FDA-1994-P-0013-0001,FDA,FDA-1994-P-0013,Letter from FDA CFSAN to Minnesota Cultivated Wild Rice Council,Other,Letter(s),1995-04-24T04:00:00Z,1995,4,,,2024-06-27T03:29:24Z,,0,0,09000064804fc7a4
FDA-1981-N-0013-0012,FDA,FDA-1981-N-0013,HFA-305 to SmithKline Beecham Consumer Healthcare,Other,ACK-Acknowledgement Letter,1995-04-14T04:00:00Z,1995,4,,,2008-05-30T22:52:38Z,,0,0,09000064805aec25
FDA-1995-P-0035-0002,FDA,FDA-1995-P-0035,HFA-305 to Arnold & Porter,Other,ACK-Acknowledgement Letter,1995-03-31T05:00:00Z,1995,3,,,2008-05-16T23:07:26Z,,0,0,090000648055af3a
FDA-1981-N-0013-0013,FDA,FDA-1981-N-0013,HFA-305 to SmithKline Beecham Consumer Healthcare,Other,ACK-Acknowledgement Letter,1995-03-29T05:00:00Z,1995,3,,,2008-05-30T22:53:17Z,,0,0,09000064805aec26
FDA-1978-N-0018-0138,FDA,FDA-1978-N-0018,"Memorandum of Meeting Between FDA and  Givaudan-Roure, et al. March 6, 1995",Other,Memorandum,1995-03-27T05:00:00Z,1995,3,,,2019-07-23T13:26:06Z,,0,0,090000648055a22b
FDA-1995-G-0034-0001,FDA,FDA-1995-G-0034,FDA/CVM to Degussa Corporation (Keller & Heckman) - Letter,Other,Letter(s),1995-03-23T05:00:00Z,1995,3,,,2013-07-27T21:36:27Z,,0,0,090000648055ae18
FDA-1995-P-0045-0002,FDA,FDA-1995-P-0045,Acknowledgment Letter from FDA DMB to Lyn O' Brien Nabors,Other,Acknowledgement Letter/Receipt,1995-03-20T05:00:00Z,1995,3,,,2025-07-21T21:30:16Z,,0,0,09000064805614fe
FDA-2020-D-1968-0001,FDA,FDA-2020-D-1968,CPG Sec. 355.300 Ion Generating Devices,Other,Guidance,1995-03-01T05:00:00Z,1995,3,2020-09-21T04:00:00Z,,2024-11-06T23:38:56Z,,1,0,0900006484868f5e
FDA-1995-P-0415-0001,FDA,FDA-1995-P-0415,Acknowledgment Letter from FDA DDM to Schering Corporation,Other,Acknowledgement Letter/Receipt,1995-03-01T05:00:00Z,1995,3,,,2017-02-04T19:56:21Z,,0,0,09000064805a6462
FDA-2020-D-1969-0001,FDA,FDA-2020-D-1969,CPG Sec. 390.425 Records and Reports; Applicability - 21 CFR 1002.1,Other,Guidance,1995-03-01T05:00:00Z,1995,3,2020-09-21T04:00:00Z,,2024-11-12T23:25:11Z,,1,0,0900006484868f60
FDA-2010-N-0551-0002,FDA,FDA-2010-N-0551,"CPG Sec. 393.200 Laser(s) as Medical Devices for Facelift, Wrinkle Removal, Acupuncture, Auricular Stimulation, etc. (CPG 7133.21)",Other,Guidance,1995-03-01T05:00:00Z,1995,3,2020-09-30T04:00:00Z,,2024-11-12T23:26:10Z,,1,0,09000064848a4277
FDA-2020-D-1962-0001,FDA,FDA-2020-D-1962,CPG Sec. 300.400 Contamination of Devices Labeled as Sterile,Other,Guidance,1995-03-01T05:00:00Z,1995,3,2020-09-21T04:00:00Z,,2024-11-06T23:38:58Z,,1,0,0900006484866867
FDA-1984-D-0144-0002,FDA,FDA-1984-D-0144,CPG Sec. 370.100 Cytotoxic Testing for Allergic Diseases (CPG 7124.27),Other,Guidance,1995-03-01T05:00:00Z,1995,3,2020-09-30T04:00:00Z,,2024-11-06T23:39:54Z,,1,0,09000064848a4275
FDA-2020-D-1964-0001,FDA,FDA-2020-D-1964,"CPG Sec. 335.500 Razor Blades, Manicuring Instruments - Not Considered Devices Under 201(h)",Other,Guidance,1995-03-01T05:00:00Z,1995,3,2020-09-21T04:00:00Z,,2024-11-06T23:38:58Z,,1,0,090000648486686b
FDA-2020-D-1970-0001,FDA,FDA-2020-D-1970,CPG Sec. 391.200 Warning Statement in Advertisements for High-Intensity Mercury Vapor Discharge Lamps that are not Self-Extinguishing (21 CFR 1040.30(e)(3)*),Other,Guidance,1995-03-01T05:00:00Z,1995,3,2020-09-21T04:00:00Z,,2024-11-06T23:38:56Z,,1,0,0900006484868f82
FDA-1984-D-0144-0001,FDA,FDA-1984-D-0144,CPG Sec. 370.100 Cytotoxic Testing for Allergic Diseases,Other,Guidance,1995-03-01T05:00:00Z,1995,3,2020-09-30T04:00:00Z,,2024-11-12T23:26:11Z,,1,0,09000064848a4273
FDA-2020-D-1966-0001,FDA,FDA-2020-D-1966,CPG Sec. 345.300 Menstrual Sponges,Other,Guidance,1995-03-01T05:00:00Z,1995,3,2020-09-21T04:00:00Z,,2024-11-06T23:38:56Z,,1,0,0900006484868f5a
FDA-2020-D-1967-0001,FDA,FDA-2020-D-1967,CPG Sec. 355.200 Electrical Muscle Stimulators,Other,Guidance,1995-03-01T05:00:00Z,1995,3,2020-09-21T04:00:00Z,,2024-11-12T23:25:06Z,,1,0,0900006484868f5c
FDA-2020-D-1975-0001,FDA,FDA-2020-D-1975,CPG Sec. 398.200 Hazardous Diagnostic X-ray Systems,Other,Guidance,1995-02-28T05:00:00Z,1995,2,2020-09-22T04:00:00Z,,2024-11-12T23:25:06Z,,1,0,0900006484868fa1
FDA-1995-P-0024-0001,FDA,FDA-1995-P-0024,HFA-305 to McKenna & Cuneo,Other,ACK-Acknowledgement Letter,1995-02-28T05:00:00Z,1995,2,,,2008-05-16T23:07:15Z,,0,0,0900006480559760
FDA-2020-D-1971-0001,FDA,FDA-2020-D-1971,CPG Sec. 300.300 Ineffective Devices - 502(f)(I) Labeling Requirements,Other,Guidance,1995-02-28T05:00:00Z,1995,2,2020-09-21T04:00:00Z,,2024-11-12T23:25:11Z,,1,0,0900006484868f84
FDA-2020-D-1972-0001,FDA,FDA-2020-D-1972,CPG Sec. 310.100 Pacemaker Reuse,Other,Guidance,1995-02-28T05:00:00Z,1995,2,2020-09-21T04:00:00Z,,2024-11-06T23:38:56Z,,1,0,0900006484868f86
FDA-2020-D-1974-0001,FDA,FDA-2020-D-1974,"CPG Sec. 397.100 Accuracy Requirements for Indication of Temporal-Maximum Ultrasonic Power, 21 CFR 1050.10(c)(1)(ii)",Other,Guidance,1995-02-28T05:00:00Z,1995,2,2020-09-22T04:00:00Z,,2024-11-06T23:38:57Z,,1,0,0900006484868f8a
FDA-1981-N-0012-0014,FDA,FDA-1981-N-0012,"HFA-305 to Caprice-Grestoke, Ltd.",Other,ACK-Acknowledgement Letter,1995-02-09T05:00:00Z,1995,2,,,2008-05-30T22:53:16Z,,0,0,09000064805ae8d9
FDA-1981-N-0012-0012,FDA,FDA-1981-N-0012,"HFA-305 to Caprice-Grestoke, Ltd",Other,ACK-Acknowledgement Letter,1995-02-02T05:00:00Z,1995,2,,,2008-05-30T22:53:23Z,,0,0,09000064805ae8d7
FDA-1981-N-0012-0013,FDA,FDA-1981-N-0012,"HFA-305 to Caprice-Grestoke, Ltd",Other,ACK-Acknowledgement Letter,1995-02-02T05:00:00Z,1995,2,,,2008-05-30T22:53:16Z,,0,0,09000064805ae8d8
FDA-1995-P-0051-0003,FDA,FDA-1995-P-0051,Acknowledgment Letter from FDA DMB to Cancer Prevention Coalition,Other,Acknowledgement Letter/Receipt,1995-01-24T05:00:00Z,1995,1,,,2025-09-15T21:40:34Z,,0,0,0900006480561e5a
FDA-1978-N-0018-0137,FDA,FDA-1978-N-0018,"Letter from FDA CDER to The Cosmetic, Toiletry & Fragrance Association",Other,Letter(s),1995-01-17T05:00:00Z,1995,1,,,2019-07-23T13:04:51Z,,0,0,090000648055a1e9
FDA-1978-N-0018-0136,FDA,FDA-1978-N-0018,Letter from FDA CDER to Nonprescription Drug Manufacturers Association,Other,Letter(s),1995-01-17T05:00:00Z,1995,1,,,2019-07-22T18:10:56Z,,0,0,090000648055a1e7